Two main classes of pharmaceutical therapies that use different mechanisms of action to treat presbyopia may be effective, noninvasive solutions for patients who are not yet good candidates for surgery.
Reading glasses, surgery and contact lenses are currently the only ways to treat presbyopia. However, several companies have ongoing clinical trials to investigate the use of miotic agents and lens-softening eye drops, Sheri L. Rowen, MD, told Ocular Surgery News.
“These two classes of drops are very promising new modalities of pharmaceutical treatments for the treatment of presbyopia. In
Uncategorized